ROCKET PHARMACEUTICALS, INC.·4

Jul 8, 4:05 PM ET

Ondrey Aaron 4

4 · ROCKET PHARMACEUTICALS, INC. · Filed Jul 8, 2025

Insider Transaction Report

Form 4
Period: 2025-07-03
Ondrey Aaron
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2025-07-03$2.88/sh1,477$4,257128,173 total
Footnotes (2)
  • [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
  • [F2]The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4